Published in Expert Rev Gastroenterol Hepatol on May 20, 2014
Hepatitis C surveillance among youth and young adults in New York City, 2009-2013. J Urban Health (2015) 0.86
Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection. Proc Natl Acad Sci U S A (2017) 0.75
Patient Characteristics and Prescribing Patterns Associated with Sofosbuvir Treatment for Chronic HCV Infection in a Commercially Insured Population. Am Health Drug Benefits (2016) 0.75
Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology (2003) 4.10
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem (2005) 2.99
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology (2007) 2.36
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol (2012) 2.31
T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology (2006) 2.30
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology (2004) 2.17
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology (2014) 2.12
Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology (2011) 2.05
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. Hepatology (2011) 1.89
Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.89
An fMRI study measuring analgesia enhanced by religion as a belief system. Pain (2008) 1.85
Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2006) 1.59
Approaching the promise of operational tolerance in clinical transplantation. Transplantation (2011) 1.54
The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest (2004) 1.53
Early high peak hepatitis C viral load levels independently predict hepatitis C-related liver failure post-liver transplantation. Liver Transpl (2009) 1.50
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology (2007) 1.49
Naïve CD8 T cell activation by liver bone marrow-derived cells leads to a "neglected" IL-2low Bimhigh phenotype, poor CTL function and cell death. J Hepatol (2012) 1.48
Hereditary lysozyme amyloidosis: spontaneous hepatic rupture (15 years apart) in mother and daughter. role of emergency liver transplantation. Liver Transpl (2006) 1.46
Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol (2002) 1.34
The liver: a special case in transplantation tolerance. Semin Liver Dis (2007) 1.33
Pathogenesis and management of alcoholic hepatitis. J Gastroenterol Hepatol (2003) 1.28
A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Hepatology (2008) 1.27
Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology (2005) 1.25
The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J (2010) 1.24
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology (2004) 1.24
SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. J Biochem Biophys Methods (2003) 1.23
The neural basis of intuitive and counterintuitive moral judgment. Soc Cogn Affect Neurosci (2011) 1.21
Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol Alcohol (2006) 1.19
Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Immunol Cell Biol (2002) 1.16
Intrahepatic immunity: a tale of two sites? Trends Immunol (2005) 1.11
Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology (2008) 1.11
Liver fibrosis: a balance of ACEs? Clin Sci (Lond) (2007) 1.08
Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol (2006) 1.08
Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol (2003) 1.08
Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. Biochim Biophys Acta (2004) 1.06
Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. J Hepatol (2012) 1.05
Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology (2002) 1.05
Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol (2010) 1.04
Fibroblast activation protein and chronic liver disease. Front Biosci (2008) 1.03
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology (2009) 1.03
Do abnormal responses show utilitarian bias? Nature (2008) 0.99
Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transpl Immunol (2011) 0.98
Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol (2006) 0.98
Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol (2008) 0.98
Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology (2003) 0.97
Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. Biochemistry (2003) 0.97
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transpl (2013) 0.97
Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clin Transplant (2006) 0.94
Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatology (2005) 0.94
Inflammation and repair in viral hepatitis C. Dig Dis Sci (2008) 0.94
The in vivo expression of dipeptidyl peptidases 8 and 9. J Histochem Cytochem (2009) 0.93
An international comparison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on donation rates after brain death (DBD) and transplantation rates. PLoS One (2013) 0.93
Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J (2006) 0.91
Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Liver Int (2007) 0.90
Methodological Issues in the Neuroscience of Moral Judgement. Mind Lang (2010) 0.90
Non-oxidative metabolism of ethanol by rat pancreatic acini. Pancreatology (2004) 0.89
Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol (2006) 0.88
A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling. Mol Cancer Res (2011) 0.88
Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection. Transplantation (2002) 0.87
Cold or calculating? Reduced activity in the subgenual cingulate cortex reflects decreased emotional aversion to harming in counterintuitive utilitarian judgment. Cognition (2012) 0.86
Dipeptidyl peptidase IV gene family. The DPIV family. Adv Exp Med Biol (2003) 0.86
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection. Liver Transpl (2004) 0.85
Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood (2013) 0.84
Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis. J Gastroenterol Hepatol (2013) 0.84
Tolerance in liver transplantation. Best Pract Res Clin Gastroenterol (2012) 0.84
Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. World J Gastroenterol (2013) 0.84
Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. J Cell Physiol (2005) 0.84
Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. J Virol (2005) 0.83
Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl (2002) 0.83
Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance. Transpl Immunol (2009) 0.82
The hepatic transcriptome in human liver disease. Comp Hepatol (2006) 0.82
Gene array analysis and the liver. Hepatology (2002) 0.82
Structure and function in dipeptidyl peptidase IV and related proteins. Adv Exp Med Biol (2006) 0.82
Hepatic artery stenosis after liver transplantation: is endovascular treatment always necessary? Liver Transpl (2015) 0.81
Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. Biochim Biophys Acta (2005) 0.81
Early hepatocellular carcinoma - is there such a thing as too early? J Hepatol (2012) 0.81
Bone marrow stem cells and the liver: are they relevant? J Gastroenterol Hepatol (2009) 0.81
Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int (2007) 0.81
Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. J Gastroenterol Hepatol (2007) 0.81
Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver. Am J Pathol (2011) 0.81
Liver tolerance and the manipulation of immune outcomes. Inflamm Allergy Drug Targets (2008) 0.80
DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. Adv Exp Med Biol (2006) 0.80
Effect of ascites on bone density measurement in cirrhosis. J Clin Densitom (2007) 0.80
Ipilimumab-induced toxicities and the gastroenterologist. J Gastroenterol Hepatol (2015) 0.80
Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection. Adv Exp Med Biol (2003) 0.79
Isolated liver transplantation in children with cystic fibrosis--an Australian experience. Pediatr Transplant (2010) 0.79
Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. J Hepatol (2005) 0.79
Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin. Adv Exp Med Biol (2006) 0.79
Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl (2009) 0.79
Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts. Transplantation (2002) 0.79
Dietary protein intakes in patients with hepatic encephalopathy and cirrhosis: current practice in NSW and ACT. Med J Aust (2006) 0.79
Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts. Transplantation (2013) 0.79
Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection? Hepatology (2007) 0.78
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies. J Gastroenterol Hepatol (2014) 0.78
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. J Gastroenterol Hepatol (2014) 0.78
"I'll never touch it again, doctor!"--harmful drinking after liver transplantation. Hepatology (2007) 0.77
Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver Int (2012) 0.77
Differential migration of passenger leukocytes and rapid deletion of naive alloreactive CD8 T cells after mouse liver transplantation. Liver Transpl (2013) 0.77
Beyond liver fibrosis: hepatic stellate cell senescence links obesity to liver cancer by way of the microbiome. Hepatology (2014) 0.77
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage? J Gastroenterol Hepatol (2010) 0.77